Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Apr-24 4:21 PM View:  | Schoen Eric Chief Financial Officer | Pain Therapeutics Inc. (SAVA) | 17-Apr-24 | Option Exercise | 1,500 | $22.00 | $33,000.00 | 7% 21.8K to 23.3K | |
| 24-Aug-23 4:06 PM View: | Robertson Sanford Director | Pain Therapeutics Inc. (SAVA) | 23-Aug-23 | Private Purchase | 30,000 | $17.45 | $523,500.00 | 3% 1.04M to 1.07M | |
| 23-Aug-23 4:58 PM View: | Barry Richard Director | Pain Therapeutics Inc. (SAVA) | 22-Aug-23 | Purchase | 16,571 | $16.65 | $275,907.00 | 6% 276.91K to 293.48K | |
| 23-Aug-23 4:58 PM View: | Barry Richard Director | Pain Therapeutics Inc. (SAVA) | 21-Aug-23 | Private Purchase | 1,906 | $16.80 | $32,020.80 | < 1% 275.0K to 276.91K | |
| 12-Jun-23 4:53 PM View: | Scannon Patrick J Md Phd Director | Pain Therapeutics Inc. (SAVA) | 12-Jun-23 | Option Exercise | 1,000 | $0.95 | $950.00 | 100% 0 to 1.0K | |
| 25-May-23 5:11 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 24-May-23 | Payment of Exercise | 9,545 | $25.25 | $241,011.00 | (< 1%) 1.17M to 1.16M | |
| 25-May-23 5:11 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 24-May-23 | Option Exercise | 71,428 | $16.87 | $1,204,990.00 | 6% 1.1M to 1.17M | |
| 25-May-23 5:11 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 24-May-23 | Payment of Exercise | 47,723 | $25.25 | $1,205,010.00 | (4%) 1.16M to 1.12M | |
| 25-May-23 5:11 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 24-May-23 | Option Exercise | 14,285 | $16.87 | $240,988.00 | 1% 1.09M to 1.1M | |
| 10-May-23 4:08 PM View: | Robertson Sanford Director | Pain Therapeutics Inc. (SAVA) | 10-May-23 | Option Exercise | 9,284 | $17.79 | $165,170.00 | < 1% 1.03M to 1.04M | |
| 02-May-23 4:04 PM View: | Gussin Robert Z Director | Pain Therapeutics Inc. (SAVA) | 01-May-23 | Option Exercise | 9,284 | $17.79 | $165,170.00 | 696% 1.33K to 10.62K | |
| 08-Mar-23 4:12 PM View: | O Donnell Michael J Director | Pain Therapeutics Inc. (SAVA) | 07-Mar-23 | Payment of Exercise | 5,139 | $25.20 | $129,503.00 | (43%) 12.01K to 6.87K | |
| 08-Mar-23 4:07 PM View: | Barry Richard Director | Pain Therapeutics Inc. (SAVA) | 07-Mar-23 | Purchase | 77,276 | $25.76 | $1,990,630.00 | 39% 197.72K to 275.0K | |
| 08-Mar-23 4:12 PM View: | O Donnell Michael J Director | Pain Therapeutics Inc. (SAVA) | 07-Mar-23 | Option Exercise | 7,142 | $18.13 | $129,484.00 | 147% 4.87K to 12.01K | |
| 08-Mar-23 4:07 PM View: | Barry Richard Director | Pain Therapeutics Inc. (SAVA) | 06-Mar-23 | Private Purchase | 11,565 | $26.13 | $302,193.00 | 6% 186.16K to 197.72K | |
| 03-Oct-22 6:01 PM View: | Friedmann Nadav Chief Medical Officer Director | Pain Therapeutics Inc. (SAVA) | 03-Oct-22 | Option Exercise | 9,376 | $0.95 | $8,907.20 | 13% 70.68K to 80.05K | |
| 12-Sep-22 4:00 PM View: | Robertson Sanford Director | Pain Therapeutics Inc. (SAVA) | 08-Sep-22 | Option Exercise | 2,802 | $23.59 | $66,099.20 | < 1% 1.02M to 1.03M | |
| 24-Aug-22 4:02 PM View: | Kupiec James William Chief Clinical Dev. Officer | Pain Therapeutics Inc. (SAVA) | 23-Aug-22 | Private Purchase | 2,500 | $24.44 | $61,100.00 | 100% 0 to 2.5K | |
| 25-Aug-22 4:20 PM View: | Barry Richard Director | Pain Therapeutics Inc. (SAVA) | 23-Aug-22 | Private Purchase | 36,159 | $23.79 | $860,223.00 | 24% 150.0K to 186.16K | |
| 16-Aug-22 4:28 PM View: | Schoen Eric Chief Financial Officer | Pain Therapeutics Inc. (SAVA) | 12-Aug-22 | Private Purchase | 2,500 | $19.95 | $49,875.00 | 13% 19.3K to 21.8K | |
| 16-Aug-22 4:24 PM View: | Robertson Sanford Director | Pain Therapeutics Inc. (SAVA) | 12-Aug-22 | Private Purchase | 100,000 | $20.69 | $2,069,000.00 | 11% 924.76K to 1.02M | |
| 07-Jun-22 6:24 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 06-Jun-22 | Payment of Exercise | 54,720 | $27.93 | $1,528,330.00 | (5%) 1.2M to 1.14M | |
| 07-Jun-22 6:24 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 06-Jun-22 | Option Exercise | 65,368 | $23.38 | $1,528,300.00 | 6% 1.13M to 1.2M | |
| 31-May-22 4:20 PM View: | Friedmann Nadav Chief Medical Officer Director | Pain Therapeutics Inc. (SAVA) | 27-May-22 | Payment of Exercise | 24,569 | $26.66 | $655,010.00 | (26%) 95.25K to 70.68K | |
| 31-May-22 4:20 PM View: | Friedmann Nadav Chief Medical Officer Director | Pain Therapeutics Inc. (SAVA) | 27-May-22 | Option Exercise | 28,014 | $23.38 | $654,967.00 | 42% 67.23K to 95.25K | |
| 25-Apr-22 6:29 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 25-Apr-22 | Option Exercise | 49,460 | $2.40 | $118,703.00 | 5% 1.08M to 1.13M | |
| 29-Mar-22 7:20 PM View: | Gussin Robert Z Director | Pain Therapeutics Inc. (SAVA) | 29-Mar-22 | Payment of Exercise | 4,024 | $39.98 | $160,880.00 | (32%) 12.43K to 8.41K | |
| 29-Mar-22 7:20 PM View: | Gussin Robert Z Director | Pain Therapeutics Inc. (SAVA) | 29-Mar-22 | Option Exercise | 7,470 | $21.53 | $160,856.00 | 150% 4.96K to 12.43K | |
| 28-Mar-22 5:57 PM View: | Robertson Sanford Director | Pain Therapeutics Inc. (SAVA) | 25-Mar-22 | Option Exercise | 4,670 | $20.30 | $94,801.00 | < 1% 920.1K to 924.76K | |
| 03-Jan-23 10:00 PM View: | Friedmann Nadav Chief Medical Officer Director | Pain Therapeutics Inc. (SAVA) | 15-Mar-22 | Gift | 990 | -- | -- | (1%) 80.04K to 79.05K | |
| 03-Jan-23 10:00 PM View: | Friedmann Nadav Chief Medical Officer Director | Pain Therapeutics Inc. (SAVA) | 31-Jan-22 | Gift | 10 | -- | -- | (< 1%) 80.05K to 80.04K | |
| 21-Sep-21 10:00 PM View: | Gussin Robert Z Director | Pain Therapeutics Inc. (SAVA) | 15-Sep-21 | Option Exercise | 2,801 | $27.37 | $76,663.40 | 72% 3.91K to 6.71K | |
| 21-Sep-21 10:00 PM View: | Gussin Robert Z Director | Pain Therapeutics Inc. (SAVA) | 15-Sep-21 | Payment of Exercise | 1,746 | $43.92 | $76,684.30 | (26%) 6.71K to 4.96K | |
| 03-Feb-22 10:00 PM View: | Schoen Eric Chief Financial Officer | Pain Therapeutics Inc. (SAVA) | 05-Aug-21 | Gift | 8,000 | -- | -- | (29%) 27.3K to 19.3K | |
| 20-Jul-21 5:21 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 20-Jul-21 | Option Exercise | 2,801 | $20.23 | $56,664.20 | < 1% 1.08M to 1.08M | |
| 28-May-21 4:01 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 27-May-21 | Option Exercise | 56,030 | $53.55 | $3,000,410.00 | 5% 1.08M to 1.13M | 4% |
| 28-May-21 4:01 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 27-May-21 | Payment of Exercise | 53,965 | $55.60 | $3,000,450.00 | (5%) 1.13M to 1.08M | 0% |
| 31-Mar-21 9:14 PM View: | Robertson Sanford Director | Pain Therapeutics Inc. (SAVA) | 30-Mar-21 | Option Exercise | 7,472 | $40.89 | $305,521.00 | < 1% 912.62K to 920.1K | 8% |
| 03-Feb-22 10:00 PM View: | Friedmann Nadav Chief Medical Officer Director | Pain Therapeutics Inc. (SAVA) | 24-Mar-21 | Gift | 1,200 | -- | -- | (2%) 68.43K to 67.23K | |
| 18-Mar-21 4:06 PM View: | Friedmann Nadav Chief Medical Officer Director | Pain Therapeutics Inc. (SAVA) | 17-Mar-21 | Option Exercise | 28,015 | $53.55 | $1,500,200.00 | 43% 64.41K to 92.42K | 17% |
| 18-Mar-21 4:06 PM View: | Friedmann Nadav Chief Medical Officer Director | Pain Therapeutics Inc. (SAVA) | 17-Mar-21 | Payment of Exercise | 23,996 | $62.52 | $1,500,230.00 | (26%) 92.42K to 68.43K | 0% |
| 18-Mar-21 3:59 PM View: | O Donnell Michael J Director | Pain Therapeutics Inc. (SAVA) | 16-Mar-21 | Payment of Exercise | 4,387 | $52.16 | $228,826.00 | (47%) 9.26K to 4.87K | (20%) |
| 18-Mar-21 3:59 PM View: | O Donnell Michael J Director | Pain Therapeutics Inc. (SAVA) | 16-Mar-21 | Option Exercise | 4,669 | $49.00 | $228,781.00 | 102% 4.59K to 9.26K | 28% |
| 24-Sep-20 4:49 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 24-Sep-20 | Market Purchase | 10,000 | $9.59 | $95,900.00 | < 1% 1.07M to 1.08M | (22%) |
| 21-Sep-20 4:01 PM View: | Robertson Sanford Director | Pain Therapeutics Inc. (SAVA) | 18-Sep-20 | Market Purchase | 36,281 | $8.92 | $323,627.00 | 4% 876.34K to 912.62K | (16%) |
| 17-Sep-20 5:25 PM View: | Schoen Eric Chief Financial Officer | Pain Therapeutics Inc. (SAVA) | 17-Sep-20 | Market Purchase | 10,000 | $7.03 | $70,300.00 | 25% 40.6K to 50.6K | 6% |
| 17-Sep-20 5:15 PM View: | Robertson Sanford Director | Pain Therapeutics Inc. (SAVA) | 17-Sep-20 | Market Purchase | 213,719 | $6.98 | $1,491,760.00 | 32% 662.62K to 876.34K | 7% |
| 17-Sep-20 5:25 PM View: | Schoen Eric Chief Financial Officer | Pain Therapeutics Inc. (SAVA) | 17-Sep-20 | Market Purchase | 2,000 | $7.04 | $14,080.00 | 4% 50.6K to 52.6K | 6% |
| 31-Dec-19 4:10 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 31-Dec-19 | Market Purchase | 100,000 | $5.53 | $553,000.00 | 10% 968.86K to 1.07M | 36% |
| 26-Dec-19 4:03 PM View: | Barbier Remi President and CEO Director | Pain Therapeutics Inc. (SAVA) | 26-Dec-19 | Market Purchase | 10,000 | $4.15 | $41,500.00 | 1% 958.86K to 968.86K | 81% |
